03 identification of gene signatures associated with gemcitabine response in pdac patients using knn
Published 6 years ago • 298 plays • Length 14:29Download video MP4
Download video MP3
Similar videos
-
8:22
pancreatic cancer properties describe gemcitabine response
-
2:48
identification of the gemcitabine resistant signature for predicting prognosis in patients
-
5:35
01 identification of gemcitabine responder vs non responder in pdc patients
-
2:27
identification of pathway signatures associated with prognosis in pancreatic cancer
-
32:49
functionalizing the cancer genome - lynda chin
-
0:30
what does the nci's comprehensive designation mean for iu simon cancer center?
-
46:34
report on the nhgri intramural research program - dan kastner
-
3:13
gene-sequencing transforming cancer treatment
-
15:46
comprehensive molecular profiling of adrenocortical carcinoma - siyuan zheng
-
11:00
standard procedure for the curation and maintenance of cancer-specific gene lists
-
34:42
3rd nhri-tommo conference: precision medicine and learning health systems
-
24:21
understanding cognitive processes of patients behind genetic testing report
-
13:08
s3 p03: development of the human dynamic neurochemical connectome (ciprian catana)
-
14:02
manipulation of nuclear transcription factors as a tool for reversing aging - karen kurtak
-
2:20
understanding the molecular underpinnings of gynecologic cancers
-
![[gene cker] diagnosis of mutant genes derived from cancer cells (2020)](https://i.ytimg.com/vi/ZAlzDq2P16E/mqdefault.jpg)
4:21
[gene cker] diagnosis of mutant genes derived from cancer cells (2020)
-
1:21
cancer dna sequenced
-
27:55
treatment of nets, a medical oncologist's perspective, dr. hagen kennecke